Global Bowel Management Systems Markets, 2020-2025: Colostomy Bags / Irrigation Systems / Nerve Modulation Devices -

·5 min read

The "Global Bowel Management Systems Market - Forecasts from 2020 to 2025" report has been added to's offering.

The global bowel management systems market is projected to grow at a CAGR of 4.11% to reach US$918.973 million by 2025 from US$721.686 million in 2019.

The increasing number of bowel diseases and the rising geriatric population is causing the end-users to adopt bowel management systems.

Bowel management system is used for the management of fecal inconsistency in patients and help them keep the skin free from contaminants and infections. The device is a soft catheter and is inserted into the rectum for fecal management to contain and divert fecal waste.

Surge in availability of technological advanced devices for fecal management, rise in geriatric population, and increase in fecal inconsistency related disorders are the major factors that is driving the growth of the bowel management systems market. Further, growth in awareness regarding the availability of these devices accompanied with launch of new devices addressing the many unmet needs contributes to the market growth of the bowel management system market.

According to International Foundation of Gastrointestinal Disorder (IFFGD) around 10-15% of the global population has Irritable bowel syndrome (IBS). Moreover favorable reimbursement scenario in the developed economies along with the technological advancement in the bowel management systems are further contributing to the market growth.

Some of the product offerings are as follows:

  • Bioness, Inc, a company that is considered as one of the leading providers of advanced and clinically supported medical devices for the treatment of pain originating in the peripheral nerves announced that its product called the "StimRouter Neuromodulation System", has received the CE mark for approval in order to facilitate the treatment of fecal incontinence (also known as bowel incontinence). This product is available across the European region and allows the physicians to treat patients suffering from fecal incontinence or bowel incontinence by placing a small implant in the tibial nerve located near the ankle. In addition, this product is a minimally invasive and easier to implant near the Nervus Tibialis.

  • BD, which is considered among one leading medical equipment and solutions companies globally offers their product called the "BARD DIGNISHEILD Stool Management System". This product is able to effectively mitigate the damage that is caused to the delicate tissues due to any leakages, pressure or friction. It also aids the patient by protecting them from exposure, or tissue damage and odor. The system offered by the company consist of a catheter tube assemble, a 60cc syringe, , collection bag and a jelly used to lubricate the syringe. In addition, other products such as odor eliminator and a tube clam are also included.

  • B. Braun Melsungen AG, one of the leading medical products manufacturing and proving companies globally offers a range of products under its Fecal Incontinence & Bowel Management segment, which include a Rectobag and Rectal Catheter. The Rectobag is a closed system that is used for facilitating repeated intestinal salvage and diagnostics. It consists of a conical connector, a bore transfer tube with a diameter of 7.5 mm and length of 10 cm with a closing clamp. It also features a liquid and odor tight inlet and eyelets with a sturdy suspension. The product called Irrigation Catheter, which are also known as rectal catheters have a color-coded cone fitting, a closed rounded tip with 2 laterally positioned eyes.

Colostomy are estimated to hold a significant share over the forecast period owing to the high prevalence of bowel health complications

Over the forecast period, the colostomy bags are estimated to hold a significant share, which is attributed to the fact that the number of individuals suffering from diseases and complications associated with the bowel. In addition, the diseases such as Irritable Bowel Syndrome are getting more common among the older individuals. CDC (Centers for Disease Control and Prevention) estimate that, there are about 1.3 million people suffering from inflammatory bowel syndrome.

The North American region is estimated to hold a noteworthy market share growth over the forecast period owing to the rising number of serious diseases, the well positioned healthcare facilities and a well-developed healthcare infrastructure. In addition, the rising awareness among the patients regarding the risk of various bowel problems is also expected to contribute to the market share of this region. The North American region is estimated to hold a noteworthy market share growth over the forecast period owing to the fact that there has been a surge in the number of serious diseases such as intestinal cancer, colorectal cancer among the population. Consequently, the risk of the different bowel diseases affecting geriatric population are also increasing.

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

4.1. Market Drivers

4.2. Market Restraints

4.3. Porters Five Forces Analysis

4.4. Industry Value Chain Analysis

5. Global Bowel Management Systems Market Analysis, By Product

5.1. Introduction

5.2. Colostomy Bags

5.3. Irrigation Systems

5.4. Nerve Modulation Devices

5.5. Others

6. Global Bowel Management Systems Market Analysis, By Patient Type

6.1. Introduction

6.2. Adults

6.3. Paediatric

7. Global Bowel Management Systems Market Analysis, By End-User

7.1. Introduction

7.2. Hospitals

7.3. Ambulatory Centers

7.4. Home Care

8. Global Bowel Management Systems Market Analysis, By Geography

9. Competitive Environment and Analysis

9.1. Major Players and Strategy Analysis

9.2. Emerging Players and Market Lucrativeness

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix

10. Company Profiles

10.1. Cogentix Medical

10.2. Hollister Incorporated

10.3. Mbh-International A/S

10.4. Mederi Therapeutics Inc

10.5. B. Braun

10.6. Aquaflush Medical Limited

10.7. Consure

10.8. Wellsspect health care

10.9. ConvaTec Group Plc.

10.10. ProSys International Ltd.

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900